Evogene Ltd. (EVGN)

CIK 1574565 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Evogene Ltd..

Recent SEC filings

FiledFormAccession number
Sep 11, 2026SCHEDULE 13D/A0001213900-26-098957
Sep 11, 2026SCHEDULE 13D/A0001178913-26-004496
Sep 4, 20266-K0001178913-26-004425
Aug 28, 2026SCHEDULE 13D/A0001213900-26-094703
Aug 27, 20266-K0001178913-26-004270
Aug 26, 202640001178913-26-004259
Aug 18, 20266-K0001178913-26-004174
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003576
Aug 13, 2026SCHEDULE 13D/A0001213900-26-088987
Aug 13, 202640001178913-26-004095
Aug 13, 2026SCHEDULE 13D/A0001178913-26-004098
Aug 11, 2026SCHEDULE 13D0001178913-26-004023
Aug 7, 2026SCHEDULE 13D/A0001213900-26-086674
Aug 5, 202640001178913-26-003859
Jul 31, 20266-K0001178913-26-003741
Jul 27, 2026SCHEDULE 13D/A0001213900-26-081575
Jul 20, 2026SCHEDULE 13D/A0001213900-26-079584
Jul 17, 2026424B50001178913-26-003518
Jul 17, 20266-K0001178913-26-003516
Jul 10, 2026SCHEDULE 13D0001213900-26-076953
Jun 16, 20266-K0001178913-26-003200
Jun 11, 20266-K0001178913-26-003169
Jun 11, 2026424B50001178913-26-003170
May 20, 20266-K0001178913-26-002817
May 20, 2026424B30001178913-26-002848